Na Lu

Na Lu

Auto-generated profile, based on publicly available information

Na Lu

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Pharmacological Research
Verified
Journal Article
Closed access
YQYangmin Qiu
Yangmin Qiu
YCYue Cao
Yue Cao
WCWangjia Cao
Wangjia Cao
YJYifei Jia
Yifei Jia
NLNa Lu
Na Lu

1 May 2018 in Gene
Verified
Journal Article
Closed access
BLBinyan Lin
Binyan Lin
XSXiuming Song
Xiuming Song
DYDawei Yang
Dawei Yang
DBDongsheng Bai
Dongsheng Bai
YYYuyuan Yao
Yuyuan Yao
NLNa Lu
Na Lu

18 April 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LWLibin Wei
Libin Wei
YZY Zhou
Y Zhou
QDQ Dai
Q Dai
CQC Qiao
C Qiao
LZL Zhao
L Zhao
QGQ-L Guo
Q-L Guo
Oroxylin A is a major active component of the Chinese traditional medicinal plant Scutellaria baicalensis Georgi, which has been reported as a potential anticancer drug. We demonstrated that, Oroxylin A inhibited the glycolysis and the binding of hexokinase II (HK II) with mitochondria in human breast carcinoma cell lines, which was dependent on sirtuin-3 (SIRT3). The level of SIRT3 in mitochondria was increased by Oroxylin A. Then SIRT3 deacetylated cyclophilin D, diminished its peptidyl-prolyl cis-trans isomerase activity and induced its dissociation from the adenine nucleotide translocator. Finally, SIRT3-induced inactivation of cyclophilin D resulted in the detachment of mitochondrial HK II and the inhibition of glycolysis. These results have important implications for the metabolism reprogramming effect and the susceptibility to Oroxylin A-induced mitochondrial cytotoxicity through the regulation of SIRT3 in breast carcinoma.

26 November 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YYYuyuan Yao
Yuyuan Yao
QGQinglong Guo
Qinglong Guo
YCYue Cao
Yue Cao
YQYangmin Qiu
Yangmin Qiu
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan
NLNa Lu
Na Lu
Cancer-associated fibroblasts (CAFs) are activated fibroblasts associated with cancer. They have an important role in tumor growth and metastasis. Artemisinin (ART) is a sesquiterpene lactone extracted from Chinese herb qinghao, and artemether (ARM), artesunate (ARS) and dihydroartemisinin (DHA) were synthesized derivatives of artemisinin, which also have anti-malarial and anti-cancer effects such as artemisinin. In this study, we investigated the in-vitro and in-vivo effects of artemisinin derivatives on inactivating cancer-associated fibroblasts and uncovered its underlying mechanism. We demonstrated that ARS and DHA could revert L-929-CAFs and CAFs from activated to inactivated state in vitro. Mechanically, ARS and DHA could suppress TGF-β signaling to inhibit activation of L-929-CAFs and CAFs, and decreased interaction between tumor and tumor microenvironment. The results showed that ARS and DHA could suppress CAFs-induced breast cancer growth and metastasis in the orthotopic model. Conformably, ARS and DHA suppressed TGF-β signaling to inactivate cancer-associated fibroblasts and inhibit cancer metastasis in vivo. Artemisinin derivatives are potential therapeutic agents for the treatment of breast cancer.

9 April 2015 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LWLibin Wei
Libin Wei
YZY Zhou
Y Zhou
CQC Qiao
C Qiao
TNT Ni
T Ni
ZLZ Li
Z Li
NLN Lu
N Lu
Alterations of cellular metabolism play a central role in the development and progression of cancer. Oroxylin A, an active flavonoid of a Chinese traditional medicinal plant, was previously shown to modulate glycolysis in cancer cells. However, the mechanism by which oroxylin A regulates glycolysis is still not well defined. Here, we show that oroxylin A inhibits glycolysis in breast cancer cells via the Sirtuin 3 (SIRT3)-mediated destabilization of hypoxia-inducible factor 1α(HIF1α), which controls glycolytic gene expression. Oroxylin A promotes superoxide dismutase (SOD2) gene expression through SIRT3-regulated DNA-binding activity of FOXO3a and increases the activity of SOD2 by promoting SIRT3-mediated deacetylation.In vivo, oroxylin A inhibits the growth of transplanted human breast tumors associated with glycolytic suppression. These data indicate that oroxylin A inhibits glycolysis-dependent proliferation of breast cancer cells, through the suppression of HIF1αstabilization via SIRT3 activation, providing preclinical information for the cancer therapies of SIRT3 stimulation.

30 December 2023 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
DBDongsheng Bai
Dongsheng Bai
JZJiawei Zhao
Jiawei Zhao
RWRunde Wang
Runde Wang
JDJiaying Du
Jiaying Du
CZChen Zhou
Chen Zhou
NLNa Lu
Na Lu
Chemotherapy-induced mucositis represents a severe adverse outcome of cancer treatment, significantly curtailing the efficacy of these treatments and, in some cases, resulting in fatal consequences. Despite identifying intestinal epithelial cell damage as a key factor in chemotherapy-induced mucositis, the paucity of effective treatments for such damage is evident. In our study, we discovered that Eubacterium coprostanoligenes promotes mucin secretion by goblet cells, thereby fortifying the integrity of the intestinal mucus barrier. This enhanced barrier function serves to resist microbial invasion and subsequently reduces the inflammatory response. Importantly, this effect remains unobtrusive to the anti-tumor efficacy of chemotherapy drugs. Mechanistically, E. copr up-regulates the expression of AUF1, leading to the stabilization of Muc2 mRNA and an increase in mucin synthesis in goblet cells. An especially significant finding is that E. copr activates the AhR pathway, thereby promoting the expression of AUF1. In summary, our results strongly indicate that E. copr enhances the intestinal mucus barrier, effectively alleviating chemotherapy-induced intestinal mucositis by activating the AhR/AUF1 pathway, consequently enhancing Muc2 mRNA stability.